(Q39389320)

English

Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiative

scientific article published on October 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiative (English)

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

0 references

quality of life

1 reference

based on heuristic

inferred from title

author name string

M. Kulig

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

A. Leodolter

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

M. Vieth

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

E. Schulte

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

D. Jaspersen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

J. Labenz

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

T. Lind

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

W. Meyer-Sabellek

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

P. Malfertheiner

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

M. Stolte

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

S. N. Willich

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

15 October 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14535869

19 March 2024

number of pages

10

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.2003.01770.x

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535869

19 March 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01770.x

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2003.01770.x

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

767-776

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

Interpreting treatment effects in randomised trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

Is the SF-36 a valid measure of change in population health? Results from the Whitehall II Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01770.X

21 January 2018

Psychosocial factors and their role in symptomatic gastroesophageal reflux disease and functional dyspepsia.

1

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Epidemiology and natural history of gastro-oesophageal reflux disease

2

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Symptomatic gastroesophageal reflux: incidence and precipitating factors

3

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

An evidence-based appraisal of reflux disease management--the Genval Workshop Report

4

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

5

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study

6

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance

7

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation

8

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life

9

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Why do apparently healthy people use antacid tablets?

11

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?

12

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Quality of life assessment in reflux disease.

13

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

The impact of gastroesophageal reflux disease on health-related quality of life.

15

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole.

17

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease

19

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

21

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments

24

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

The MOS 36-ltem Short-Form Health Survey (SF-36)

25

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Interpretation of quality of life changes

30

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Effect sizes for interpreting changes in health status.

31

1 reference

10.1046/J.1365-2036.2003.01770.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01770.X

19 March 2024

Identifiers

10.1046/J.1365-2036.2003.01770.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39389320&oldid=2108521224"